For instance, semaphorin 3A and semaphorin 4D have been extensively documented to promote tumor progression [55,56,57], immune suppression [41], and nerve–tumor interactions, contributing directly to PNI progression [58]. This evidence concerns the gene SEMA4D and neoplasm.